Compare · AXGN vs FONR
AXGN vs FONR
Side-by-side comparison of Axogen Inc. (AXGN) and Fonar Corporation (FONR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AXGN and FONR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- AXGN is the larger of the two at $2.20B, about 17.6x FONR ($125.1M).
- Over the past year, AXGN is up 299.2% and FONR is up 31.9% - AXGN leads by 267.3 points.
- FONR has been more active in the news (18 items in the past 4 weeks vs 1 for AXGN).
- AXGN has more recent analyst coverage (8 ratings vs 0 for FONR).
- Company
- Axogen Inc.
- Fonar Corporation
- Price
- $41.48-3.13%
- $19.10+0.03%
- Market cap
- $2.20B
- $125.1M
- 1M return
- -4.49%
- +0.90%
- 1Y return
- +299.23%
- +31.91%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1981
- News (4w)
- 1
- 18
- Recent ratings
- 8
- 0
Axogen Inc.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Latest AXGN
- The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
- Director Wendell Amy Mcbride exercised 1,647 shares at a strike of $14.85 and sold $70,162 worth of shares (1,647 units at $42.60) (SEC Form 4)
- Director Johnson John sold $477,968 worth of shares (11,050 units at $43.26) and exercised 11,050 shares at a strike of $7.04 (SEC Form 4)
- Director Weiler Kathy Johnson exercised 16,344 shares at a strike of $6.95 and sold $720,623 worth of shares (16,344 units at $44.09) (SEC Form 4)
- Chief Marketing Officer Kemp Jens sold $173,761 worth of shares (4,000 units at $43.44), decreasing direct ownership by 5% to 72,451 units (SEC Form 4)
- CFO Hartley Lindsey Marie sold $45,897 worth of shares (1,051 units at $43.67) and exercised 5,463 shares at a strike of $8.24, increasing direct ownership by 7% to 65,146 units (SEC Form 4)
- Sales VP Quackenbush Doris sold $168,720 worth of shares (3,878 units at $43.51), decreasing direct ownership by 4% to 92,416 units (SEC Form 4)
- New insider Quackenbush Doris claimed ownership of 96,294 shares (SEC Form 3)
- TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
- Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
Latest FONR
- SEC Form 4 filed by Director Turk Richard E.
- SEC Form 3 filed by new insider Turk Richard E.
- SEC Form 4 filed by EVP/COO/Acting PFO Bonanni Luciano B
- EVP/COO Bonanni Luciano B was granted 47,226 units of FONAR CORPORATION COMMON STOCK, increasing direct ownership by 2,029% to 49,553 units (SEC Form 4)
- New insider Bonanni Luciano B claimed ownership of 2,327 units of FONAR CORPORATION COMMON STOCK (SEC Form 3)
- SEC Form 4 filed by President/CEO/Treasurer Damadian Timothy Raymond
- President/CEO/Treasurer Damadian Timothy Raymond was granted 26,000 units of FONAR CORPORATION COMMON STOCK and transferred by will 36,359 units of FONAR CORPORATION COMMON STOCK), increasing direct ownership by 559% to 79,059 units (SEC Form 4)
- New insider Damadian Timothy Raymond claimed ownership of 12,000 units of FONAR CORPORATION COMMON STOCK (SEC Form 3)
- Large owner Shane Hilary bought $4,113,298 worth of shares (215,336 units at $19.10) (SEC Form 4)
- SEC Form S-8 POS filed by Fonar Corporation